The Guardian: Mergers & Acquisitions

MARCH 19, 2024

The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy.

Pharmaceutical 104

Pharmaceutical Portfolio Acquisitions Business 104

Global Newswire by Notified: M&A

SEPTEMBER 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc. PRINCETON, N.J., Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions 45

Global Newswire by Notified: M&A

JULY 31, 2023

July 31, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. CORONA, Calif.,

Acquisitions 75

Acquisitions Pharmaceutical Corporation IT 75

Global Newswire by Notified: M&A

SEPTEMBER 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. PRINCETON, N.J., Alimera”) (Nasdaq: ALIM).

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

OCTOBER 17, 2024

AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

Pharmaceutical 45

Pharmaceutical Healthcare Acquisitions IT 45

Global Newswire by Notified: M&A

SEPTEMBER 26, 2023

OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired: CHINO HILLS, Calif., 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc.

Pharmaceutical 102

Pharmaceutical IT Manufacturing Acquisitions 102

The Guardian: Mergers & Acquisitions

DECEMBER 26, 2023

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker AstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market.

Pharmaceutical 96

Pharmaceutical Acquisitions IT Medical 96

Deal Lawyers

OCTOBER 4, 2024

Alexion Pharmaceuticals, Inc. — both involving acquisitions of development-stage biotech companies and both interpreting an earnout provision’s objective or outward-facing definition of “commercially reasonable efforts.” and Himawan v. Cephalon, Inc.

Pharmaceutical 100

Pharmaceutical Acquisitions 100

Global Newswire by Notified: M&A

JUNE 9, 2024

Selechimica”), an Italian distributor in the pharmaceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L.

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

APRIL 23, 2024

a European distributor in the pharmaceutical and nutraceutical industry. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U,

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

SEPTEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., SAN DIEGO, Sept.

Pharmaceutical 40

Pharmaceutical Acquisitions Business 40

Global Newswire by Notified: M&A

OCTOBER 21, 2024

21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn ™ (iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from CiVi Biopharma. Philadelphia, PA, Oct.

Pharmaceutical 40

Pharmaceutical Acquisitions Portfolio 40

Global Newswire by Notified: M&A

JULY 14, 2024

July 15, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that its previously announced acquisition by the global pharmaceutical company, AstraZeneca, has closed.

Acquisitions 49

Acquisitions Pharmaceutical IT 49

Global Newswire by Notified: M&A

OCTOBER 9, 2024

Cergy, 9 October 2024 - SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 88% of Spefinox, an expert player in industrial processes for the agri-food, cosmetics and pharmaceuticals sectors.

Acquisitions 52

Acquisitions Pharmaceutical Food 52

Global Newswire by Notified: M&A

MAY 1, 2024

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries.

Pharmaceutical 40

Pharmaceutical Shares Acquisitions 40

Global Newswire by Notified: M&A

JULY 31, 2024

Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of RSDL ® (Reactive Skin Decontamination Lotion) kit from Emergent BioSolutions Inc. NYSE: EBS) for an up-front payment of approximately $75 million.

Pharmaceutical 40

Pharmaceutical Acquisitions Medical Manufacturing 40

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

NOVEMBER 27, 2023

27, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Scientific Support Services Ltd (“SSS” or the “Company”), a UK based provider of scientific instruments, supplies and services to customers in the petrochemical, environmental, pharmaceutical, clinical, and food and flavors sectors.

Pharmaceutical 80

Pharmaceutical Food Acquisitions IT 80

Global Newswire by Notified: M&A

OCTOBER 6, 2023

PRESIDIO PROPERTY TRUST ANNOUNCES CLOSING OF MERGER OF ITS SPONSORED SPAC MURPHY CANYON ACQUISITION CORP NOW TRADING AS CONDUIT PHARMACEUTICALS.

Pharmaceutical 40

Pharmaceutical Mergers and Acquisitions Mergers Trading 40

Global Newswire by Notified: M&A

SEPTEMBER 21, 2023

21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced today the completion of their acquisition of Paratek Pharmaceuticals, Inc. CAMBRIDGE, Mass.,

Pharmaceutical 40

Pharmaceutical Capital Acquisitions 40

Global Newswire by Notified: M&A

NOVEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. VANCOUVER, British Columbia, Nov.

Pharmaceutical 49

Pharmaceutical Equities IT Negotiation 49

Global Newswire by Notified: M&A

SEPTEMBER 4, 2024

Olon, the leading chemical-pharmaceutical group in the production and development of active pharmaceutical ingredients (APIs) and part of the holding company P&R, continues its growth path and announces a new venture: it will acquire HuvePharma Italia Srl and its site in Garessio, (Cuneo, Italy) with a significant increase in its total production (..)

Pharmaceutical 52

Pharmaceutical IT Acquisitions 52

Global Newswire by Notified: M&A

DECEMBER 31, 2024

Galeras development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer.

Pharmaceutical 45

Pharmaceutical Acquisitions 45

Global Newswire by Notified: M&A

MARCH 27, 2024

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc.

Pharmaceutical 40

Pharmaceutical Equities Acquisitions IT 40

Global Newswire by Notified: M&A

MARCH 5, 2025

Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation

Pharmaceutical 40

Pharmaceutical Acquisitions Management IT 40

Global Newswire by Notified: M&A

OCTOBER 4, 2023

04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. Purchaser”), to purchase all outstanding shares of Zynerba common stock. The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.

Pharmaceutical 40

Pharmaceutical Shares Stock Acquisitions 40

Global Newswire by Notified: M&A

JANUARY 27, 2025

28, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of RLS (USA) Inc. MELBOURNE, Australia and INDIANAPOLIS, Jan.

Acquisitions 40

Acquisitions Pharmaceutical IT 40

Global Newswire by Notified: M&A

JULY 3, 2023

Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia

Pharmaceutical 40

Pharmaceutical Acquisitions Management 40

Global Newswire by Notified: M&A

JUNE 18, 2024

(TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé ("Virage"), a company specializing in the manufacturing and marketing of natural health products ("NHPs"), based in Lévis, Quebec.

Acquisitions 40

Acquisitions Pharmaceutical Manufacturing IT 40

The Guardian: Mergers & Acquisitions

OCTOBER 21, 2024

Move follows fears over jobs and control when private equity firm CD&R entered talks to buy Opella for €16bn The French government is to take a stake in the pharmaceutical company Sanofi’s consumer healthcare division to try to quell a backlash as the US private equity firm Clayton, Dubilier & Rice enters talks to buy the unit for €16bn (£13.3bn). (..)

Private Equity 77

Private Equity Pharmaceutical Sale Equities 77

Global Newswire by Notified: M&A

DECEMBER 5, 2023

Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment

Acquisitions 45

Acquisitions Pharmaceutical Portfolio 45

Global Newswire by Notified: M&A

JANUARY 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- Evaluate , a Norstella company, announced today the acquisition of J+D Forecasting , a leading provider of forecasting solutions for the pharmaceutical industry. London, UK & Boston, MA, Jan.

Acquisitions 40

Acquisitions Pharmaceutical 40

Global Newswire by Notified: M&A

JUNE 10, 2025

OQM”) of a controlling interest in AdBioTech Co.,

Acquisitions 40

Acquisitions Pharmaceutical Consulting Funds 40

Global Newswire by Notified: M&A

SEPTEMBER 20, 2023

Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets. Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets.

Pharmaceutical 52

Pharmaceutical Portfolio Acquisitions 52

Global Newswire by Notified: M&A

JUNE 24, 2024

Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approximately.

Pharmaceutical 45

Pharmaceutical Business Acquisitions 45

Solganick & Co.

SEPTEMBER 2, 2024

September 2, 2024 – The software mergers and acquisitions (M&A) marketplace has been bustling with activity in the first half of 2024, reflecting the sector’s robust growth and strategic consolidations. billion acquisition of Ansys, a move aimed at bolstering its software capabilities and expanding its market footprint.

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52